These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 3054491)
21. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Grubman MJ Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996 [TBL] [Abstract][Full Text] [Related]
22. Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins. Whitehead SS; Hruby DE Virology; 1994 Apr; 200(1):154-61. PubMed ID: 8128619 [TBL] [Abstract][Full Text] [Related]
23. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
25. Proteolytic processing of picornaviral polyprotein. Palmenberg AC Annu Rev Microbiol; 1990; 44():603-23. PubMed ID: 2252396 [No Abstract] [Full Text] [Related]
26. Molecular genetic and biochemical evidence for the involvement of the heptapeptide cleavage sequence in determining the reaction profile at two tobacco etch virus cleavage sites in cell-free assays. Dougherty WG; Parks TD Virology; 1989 Sep; 172(1):145-55. PubMed ID: 2672562 [TBL] [Abstract][Full Text] [Related]
27. Proteomics approaches for the identification of protease substrates during virus infection. Martiáñez-Vendrell X; Kikkert M Adv Virus Res; 2021; 109():135-161. PubMed ID: 33934826 [TBL] [Abstract][Full Text] [Related]
28. The recognition event between virus and host cell receptor: a target for antiviral agents. Lentz TL J Gen Virol; 1990 Apr; 71 ( Pt 4)():751-66. PubMed ID: 2109039 [No Abstract] [Full Text] [Related]
29. Viral proteinases. Kräusslich HG; Wimmer E Annu Rev Biochem; 1988; 57():701-54. PubMed ID: 3052288 [No Abstract] [Full Text] [Related]
30. Genetically engineered herpesvirus vaccines. Accomplishments in pigs and prospects in humans. Kit S; Kit M Prog Med Virol; 1991; 38():128-66. PubMed ID: 1647043 [No Abstract] [Full Text] [Related]
31. Partial characterization of a P70 proteolytic factor that is present in purified virions of Rauscher leukemia virus (RLV). Yoshinaka Y; Luftig RB Biochem Biophys Res Commun; 1977 May; 76(1):54-63. PubMed ID: 869948 [No Abstract] [Full Text] [Related]
32. Proteolytic processing of animal virus proteins. Butterworth BE Curr Top Microbiol Immunol; 1977; 77():1-41. PubMed ID: 72634 [No Abstract] [Full Text] [Related]
33. Protein cleavage during virus assembly: characterization of cleavage in T4 phage. Tsugita A; Black LW; Showe MK J Mol Biol; 1975 Oct; 98(1):217-5. PubMed ID: 1195380 [No Abstract] [Full Text] [Related]
37. The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways. Mort JS; Buttle DJ Mol Pathol; 1999 Feb; 52(1):11-8. PubMed ID: 10439833 [TBL] [Abstract][Full Text] [Related]
38. Stalking new vaccines: Methods that target the stems of viral proteins could put universal vaccines within reach. Arnold C Nat Med; 2017 Nov; 23(11):1248-1250. PubMed ID: 29117168 [No Abstract] [Full Text] [Related]
39. [Molecular mechanisms of proteolytic processing of viral proteins and the problem of antiviral chemotherapy and vaccine design]. Zhirnov OP Mol Biol (Mosk); 1988; 22(3):581-600. PubMed ID: 3054491 [TBL] [Abstract][Full Text] [Related]
40. [Proteolytic processing of viral and bacterial proteins and its potentials in controlled modification for vaccine design]. Zhirnov OP Mol Gen Mikrobiol Virusol; 1986 Aug; (8):3-8. PubMed ID: 3537769 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]